Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UPM Biomedicals and CELLINK form collaboration for groundbreaking 3D bioprinting developments

(UPM, Helsinki, 10 March 2021 at 10:00 EET) – UPM Biomedicals is excited to announce its collaboration with bioconvergence company CELLINK. The partnership brings together UPM’s expertise for producing non-animal derived, nanocellulose biomaterials with CELLINK’s years of experience in method development for 3D bioprinting, offering new groundbreaking solutions to this growing life sciences market. Advances in 3D printing in the past decade have been outstanding, and the technology is becoming more widely used for various cutting-edge applications. 3D bioprinting is already important in

poLight ASA – share capital increase registered

Reference is made to the stock exchange announcement on 3 March 2021 regarding a decision by the Board of Directors of poLight ASA to increase the share capital following exercise of share options. The share capital increase has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 15 875,60 through issuance of 79 378 new shares, each with a par value of NOK 0.20. The new share capital is thus NOK 1,825,640.00 divided by 9 128 200 shares, each with a par value of NOK 0.20.

Contract Awards for four PSVs in the UK North Sea

Solstad Offshore ASA (“Solstad”) has been awarded four Platform Supply Vessel (PSV) contracts for work in the UK North Sea. Total E&P UK Limited / Total E&P North Sea UK Limited (“Total UK”) has awarded Solstad a term contract for Normand Springer. The vessel will be utilised by Total UK to support their UK North Sea assets for a charter period lasting one year firm, plus a one year option.  Commencement of this contract will be during the second half of March 2021. In addition, Equinor UK Limited has awarded Solstad two contracts for PSVs for an upcoming drilling campaign in the UK

Transactions in connection with share buy-back programme

On 4 March 2021, H+H International A/S (hereinafter referred to as “H+H” or “the Company”) initiated a share buy-back programme in compliance with Article 5 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on Market Abuse and Commission Delegated Regulation (EU) 1052/2016 of 8 March 2016 (the “Safe Harbour Regulation”). The share buy-back programme is expected to be realised over a 12-month period, starting from 4 March 2021. Under the share buy-back programme, H+H may repurchase shares up to a maximum amount of DKK 100 million, and no more

Work engagement may decrease the risk of unemployment and incapacity for work – and increase salary levels

Study: When an employee experiences work engagement, the benefits are apparent in the individual’s life as well as in society in general. Work engagement was discovered to have a positive effect in the labour market. The study conducted by the Finnish Institute of Occupational Health and Etla suggests  that it is important to pay attention to well-being at work in a proactive manner.Work engagement experienced by employees has a positive effect in the labour market. Work engagement is associated with reduced likelihood of premature disability pension and risk of unemployment. In addition,

Eric Lundberg new CEO of Apotek Hjärtat

Eric Lundberg has been appointed as the new CEO of Apotek Hjärtat. He served most recently as CEO of Kjell & Company, where he has been since 2018. Prior to this, Eric Lundberg was Director of Marketing for Apoteket AB and also held corresponding positions for companies such as Plantagen and Bauhaus.As CEO of Apotek Hjärtat, Eric Lundberg will be a member of the ICA Gruppen Management Team and will report to ICA Gruppen’s CEO, Per Strömberg. “Eric Lundberg has a long background in retail and extensive experience from transformations. In his most recent assignment, he created a successful

Ratos acquires 63 % of Vestia Construction Group

Ratos is acquiring 63% of Vestia Construction Group (“Vestia”), which is active in the expansive Gothenburg market. Vestia has recorded average annual growth of 40% over the past five years, with an adjusted EBITA margin of 6% for the 2019/2020 financial year. Vestia is expected to reach approx. 750 MSEK in revenue for current financial year.“The acquisition of Vestia is an excellent complement to our existing construction company, HENT, both geographically and in terms of expertise. The company has a strong customer-oriented culture and a transparent business model that provides a large

Acast initiates a review of potential strategic and financial initiatives

The Board of Directors of Acast today announces that it will conduct a review of potential strategic and financial initiatives, including the company's capital structure as well as an initial public offering and listing of the company’s shares. The review will be carried out during the spring 2021.   For more information: Ross Adams, CEOTel: +44 79 9052 0761Email: ross@acast.com Emily Villatte, CFOTel: +46 76 525 0142Email: emily.villatte@acast.com About AcastAcast is the power source of podcasting, offering everything creators and advertisers need to find and reach

Cantargia submits application to start new clinical trial investigating antibody CAN04 and FOLFIRINOX in pancreatic can

Cantargia AB today announced the submission of a clinical trial application investigating antibody CAN04 in combination with FOLFIRINOX for first line treatment of metastatic pancreatic cancer (PDAC). The trial is designed to complement the ongoing clinical program and subsequently broaden the development of CAN04. The phase Ib trial is planned to be performed in up to 30 patients in France and Spain. The current estimate is to start therapy in the first patient in the end of Q2 2021.Cantargia develops antibody-based pharmaceuticals against interleukin-1 receptor accessory protein (IL1RAP).

Valmet hosts a Capital Markets Day today, March 10, 2021 in a virtual format

Valmet hosts a Capital Markets Day today, March 10, 2021 in a virtual format Valmet Oyj’s press release on March 10, 2021 at 9:30 a.m. EET Valmet hosts a Capital Markets Day for institutional investors and analysts today, Wednesday, March 10, 2021 in a virtual format. The aim of the Capital Markets Day is to provide information and an update on Valmet's strategy and business outlook. Valmet’s climate program – Forward to a carbon neutral future – was published today and will also be presented in the event. Valmet's strategy and financial targets remain unchanged. The day will include

Year-End Report January - December 2020

OCT 1st – DEC 31st 2020 · Net sales amounted to EUR 6 370 thousand (4 895), a 30.1 percent increase · EBITDA of EUR 484 thousand (-283) and EBITDA margin of 7.6 percent (-5.8) · EBIT of EUR 297 thousand (-406) and EBIT margin of 4.7 percent (-8.3) · Net earnings after tax of negative EUR 272 thousand (-1 803) JAN 1st – DEC 31st 2020 · Net sales amounted to EUR 21 253 thousand (21 233) · EBITDA of EUR 961 thousand (-594) and EBITDA margin of 4.5 percent (2.8) · EBIT of EUR 480 thousand (-1 005) and EBIT margin of 2.3 percent (-4.7) · Net earnings after tax of

BioStock: BiBBInstruments brings new vision to cancer diagnostics

Despite the advancements made in cancer therapeutics over the last decade, cancer remains one of the top causes of death worldwide. Early detection plays a big role in keeping the cancer death rates low, and Swedish medtech BiBBInstruments is addressing the issue with its EndoDrill Model X, the first CE-marked electric endoscopic biopsy device.  The device can provide better tumour samples, which can result in a more complete and accurate cancer diagnosis and thus lead to earlier treatment in patients afflicted by some of the most serious cancers. BioStock spoke with the company’s CEO Fredrik

Quantum-proof crypto from Sectra receives SECRET approval from EU

Linköping, Sweden – March 10, 2021 – The EU council has approved the latest version of the eavesdrop-proof mobile phone Sectra Tiger/S 7401 LTE from international cybersecurity and medical imaging IT company Sectra  (STO: SECT B). This approval, which applies to the security level SECRET, certifies the latest Sectra Tiger/S version for sharing information that, if it fell into the wrong hands, could severely damage the security of the EU and its member nations.Sectra Tiger/S is quantum-proof, and the latest version includes features such as improved file transfer and

Solar cells for just over 3,100 square meters of roof

Wallenstam is continuing its investment in installation of solar cells in the existing property holdings. Right now, 245 solar cell modules are being installed on Trollesundsvägen in Bandhagen. To date, a total of almost 1,800 units will soon have been installed on just over 3,100 square meters of roof. This is a conscious investment that will contribute to a climate-smart everyday life for Wallenstam’s tenants and at the same time is expected to generate more than 509,000 kWh of locally produced renewable energy.Wallenstam was the first in the sector to be self-sufficient in renewable

PPG Industries, Inc. supplements the tender offer document dated January 14, 2021 relating to the voluntary recommended public cash tender offer for all the shares in Tikkurila Oyj

TIKKURILA OYJTender Offer March 10, 2021 at 9.05 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. PPG Industries, Inc. (“PPG” or the “Offeror”), a corporation incorporated under the laws of Pennsylvania, and Tikkurila Oyj (“Tikkurila” or the “Company”) have on December 18, 2020 entered into a combination agreement (the “Combination Agreement”), which was amended

Peab rebuilds wastewater treatment plant in Henriksdal

Peab has been commissioned to rebuild a wastewater treatment plant in Henriksdal, Stockholm. The customer is Stockholm Vatten och Avfall and the contract is worth SEK 254 million.Stockholm Vatten och Avfall is running the project Stockholm’s future wastewater treatment. It comprises a new wastewater tunnel from Bromma to the Sickla plant in Hammarbybacken and a new plant in Sickla along with rebuilding existing basins in Henriksdal. Peab will be rebuilding in preparation for installation of the new and improved biological treatment process. The commission consists of four aeration basins

Eklund Foundation for Odontological Research and Education allocates €220,000 in 2021

€220,000 in research support – that is the total sum allocated by the Board of Eklund Foundation in 2021. In May, the application portal is open for researchers within all fields of dentistry and from all parts of the world for the sixth year running.Both experimental and clinical studies within all fields of dentistry are welcome, but projects that can be related to periodontology, implantology, or cariology will be prioritised. Researchers may apply for funding for a project in its entirety, or for part of a project. Even though the application period runs from 1 to 31 May, the

Securitas presents new global brand identity

· New brand highlights Securitas’ human and progressive approach and the positive impact of its innovation and technology · Brand headlined by tagline ‘See a different world’ · Securitas logo receives first major update since 1972 Securitas, the world’s leading intelligent protective services partner, has launched a major update to its global brand identity and positioning. Headlined by the tagline ‘See a different world’, the new brand highlights the company’s human and progressive approach to security, and the positive impact of its innovation and technology. It includes the

Stayble appoints Professor Hans Jörg Meisel as a member of the scientific advisory board

Stayble Therapeutics today announced that the company’s scientific advisory board gains new expertise through the appointment of Professor Hans Jörg Meisel, Berlin, Germany. Prof. Meisel adds further expertise in medical innovation and clinical trials in degenerative spinal diseases and a European perspective to the company’s scientific advisory board.Anders Lehmann, Chief Scientific Officer comments: “We are excited about the appointment of Prof. Meisel, a leading expert in advanced therapies for low back pain with a long-standing and extensive experience in spinal diseases. His

Cessatech A/S (“Cessatech” or the “Company”) hereby convenes the annual general meeting to be held on 26 March 2021.

The shareholders of Cessatech A/S The board of directors hereby convenes the annual general meeting of Cessatech to be held on Friday 26 March 2021 at 8.00 (CET) at the Company's address Kanonbådsvej 2, 1437 København K. To reduce the risk of COVID-19 spreading, the Board of Directors urges shareholders to refrain from attending the extraordinary general meeting in person and instead cast their votes by correspondence or proxy and watch the general meeting via webcast.The agenda for the general meeting is as follows: 1. ELECTION OF CHAIRMAN OF THE MEETING 2. REPORT ON THE

Metacon reinforce within business development

Metacon AB announced today that Mr. Christian Hofmann has been appointed Business Development Director, effective immediately.Mr. Hofmann has been working professionally for over 20 years with the energetic and material use of biomass and has researched on the topic of hydrogen production from biomass as part of his Phd. Before joining Metacon, Mr. Hofmann was CEO in the biogas sector, technical director in energy plant construction and business developer in the finance segment. He has lived and worked, among other things, in Germany, Austria, Switzerland and Sweden. "We are very pleased

Valmet introduces its climate program – Forward to a carbon neutral future

Valmet Oyj’s press release on March 10, 2021 at 9:00 a.m. EETValmet introduces its climate program – Forward to a carbon neutral future – in the company’s Capital Markets Day on March 10, 2021. The program continues Valmet’s comprehensive work for sustainability.  Valmet’s climate program includes ambitious CO₂ emission reduction targets and concrete actions for the whole value chain, including Valmet’s own operations, the supply chain, and the use of Valmet’s technologies by its customers. The program is aligned with the Paris Climate Agreement’s 1.5-degree pathway and the United

Major US OEM awards Concentric AB a new contract to supply electro hydraulic steering (EHS) pumps for the next generation steering system on electric refuse trucks

Concentric AB has been awarded a strategically important contract for its EHS pump by a major global US OEM which will be used in their new electric refuse truck. These trucks will be deployed across the US starting in New York, the world’s largest municipal sanitation department. Production will start in 2021 and sales revenues from this new contract are estimated to be worth MSEK 16 over the next five years.Local city regulations continue to drive increased demand for electric commercial vehicles as cities legislate to reduce CO\2\ emissions to achieve their greenhouse gas goals. Buses

Cambri Secures €3.6M Series A Funding Round with Game-Changing Product and Concept Testing Solution for Consumer Brands

--Funding from OpenOcean and Spintop Ventures to accelerate Cambri and its game-changing Saas solution that empowers brands to dramatically reduce the 80% failure rate of product launches.---Industry leader Lynda Clarizio joins the Board of Directors, adding vast expertise in enterprise data and analytics. Background in media, advertising and software industries, as well as numerous Board roles and former President at Nielsen US Media.Cambri , a Nordic-based market research automation and SaaS startup that accelerates product and concept testing of consumer brands,

There are no items matching the current filter
There are no more items matching the current filter
Back to top